Year None20232022202120202019 NEWS RELEASE 11.22.2023 AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE NEWS RELEASE 11.10.2023 AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023 NEWS RELEASE 11.07.2023 AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023 NEWS RELEASE 11.07.2023 AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023 NEWS RELEASE 11.02.2023 AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE) NEWS RELEASE 11.01.2023 AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO NEWS RELEASE 10.31.2023 AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS NEWS RELEASE 10.25.2023 AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS NEWS RELEASE 10.24.2023 AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND NEWS RELEASE 10.22.2023 AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER NEWS RELEASE 10.20.2023 AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER NEWS RELEASE 10.19.2023 AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023 NEWS RELEASE 10.16.2023 AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023 NEWS RELEASE 10.06.2023 AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC NEWS RELEASE 09.20.2023 AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS NEWS RELEASE 09.11.2023 AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE NEWS RELEASE 09.10.2023 AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC NEWS RELEASE 09.07.2023 AMGEN TO PRESENT AT THE MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE NEWS RELEASE 09.01.2023 AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION NEWS RELEASE 08.31.2023 AMGEN TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE AND THE CITI GLOBAL HEALTHCARE CONFERENCE NEWS RELEASE 08.26.2023 AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023 NEWS RELEASE 08.21.2023 AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS® (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING NEWS RELEASE 08.03.2023 AMGEN REPORTS SECOND QUARTER FINANCIAL RESULTS NEWS RELEASE 08.01.2023 AMGEN ANNOUNCES 2023 THIRD QUARTER DIVIDEND NEWS RELEASE 07.31.2023 AMGEN ANNOUNCES WEBCAST OF 2023 SECOND QUARTER FINANCIAL RESULTS NEWS RELEASE 06.21.2023 FDA GRANTS FULL APPROVAL FOR BLINCYTO® (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA NEWS RELEASE 06.09.2023 AMGEN TO PRESENT AT THE GOLDMAN SACHS 44TH ANNUAL GLOBAL HEALTHCARE CONFERENCE NEWS RELEASE 06.04.2023 AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023 NEWS RELEASE 06.01.2023 AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL RESEARCH ACROSS ITS DIVERSE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2023 NEWS RELEASE 05.30.2023 AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023 NEWS RELEASE 05.26.2023 AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT NEWS RELEASE 05.16.2023 AMGEN RESPONDS TO FTC ACTION RE: PROPOSED ACQUISITION OF HORIZON THERAPEUTICS NEWS RELEASE 05.09.2023 AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN'S DISEASE NEWS RELEASE 05.08.2023 NEW DATA FROM AMGEN'S PROLIA® (DENOSUMAB) DEMONSTRATES SIGNIFICANT REDUCTION IN OSTEOPOROTIC FRACTURE RISK COMPARED TO ALENDRONATE NEWS RELEASE 05.03.2023 AMGEN TO PRESENT AT THE 2023 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE NEWS RELEASE 04.27.2023 AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS NEWS RELEASE 04.21.2023 AMGEN ANNOUNCES WEBCAST OF 2023 FIRST QUARTER FINANCIAL RESULTS NEWS RELEASE 04.19.2023 AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST) NEWS RELEASE 03.09.2023 AMGEN TO PRESENT AT THE 33rd ANNUAL OPPENHEIMER HEALTHCARE CONFERENCE NEWS RELEASE 03.07.2023 AMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND NEWS RELEASE 03.03.2023 AMGEN TO PRESENT AT THE 43RD ANNUAL TD COWEN HEALTHCARE CONFERENCE NEWS RELEASE 03.01.2023 AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC NEWS RELEASE 02.22.2023 AMGEN ANNOUNCES CARDIOVASCULAR STUDY TO EVALUATE ASSOCIATION BETWEEN LIPOPROTEIN(a) AND CARDIOVASCULAR RISK IN AFRICAN AMERICANS NEWS RELEASE 02.09.2023 AMGEN TO PRESENT AT THE 2023 SVB SECURITIES GLOBAL BIOPHARMA CONFERENCE NEWS RELEASE 02.02.2023 TEZSPIRE® APPROVED FOR SELF-ADMINISTRATION IN THE U.S. WITH A NEW PRE-FILLED PEN NEWS RELEASE 01.31.2023 AMGEN POSTS FULL TRANSCRIPT AND AUDIO REPLAY OF FOURTH QUARTER AND FULL YEAR 2022 EARNINGS WEBCAST NEWS RELEASE 01.31.2023 AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS NEWS RELEASE 01.31.2023 AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES NEWS RELEASE 01.26.2023 AMGEN ANNOUNCES WEBCAST OF 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS NEWS RELEASE 01.06.2023 AMGEN AND BIOLABS LA AT THE LUNDQUIST INSTITUTE ANNOUNCE NAMMI THERAPEUTICS TO RECEIVE THE THIRD AMGEN GOLDEN TICKET NEWS RELEASE 01.04.2023 AMGEN TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE